Foscarnet Sodium Fresenius Kabi Ltd (Foscarnet Sodium Hexahydrate)

Foscarnet Sodium Hexahydrate is an antiviral medication used to treat certain viral infections. It is administered intravenously and is manufactured by Fresenius Kabi Limited.

Foscarnet Sodium Hexahydrate is primarily used for the treatment of viral infections, particularly those caused by herpesviruses. It is often prescribed for conditions where other antiviral treatments may not be effective. This medication works by inhibiting the replication of the virus, helping to manage and control the infection.

Common effects of Foscarnet Sodium Hexahydrate may include nausea, vomiting, and changes in kidney function. Some individuals may also experience electrolyte imbalances or changes in blood cell counts. It is important to monitor these effects closely during treatment.

Foscarnet Sodium Hexahydrate should be used with caution in individuals with kidney problems or those who are dehydrated. Regular monitoring of kidney function and electrolyte levels is recommended. It is also important to stay well-hydrated during treatment.

Foscarnet Sodium Hexahydrate may interact with other medications, particularly those that affect kidney function or electrolyte balance. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.